Share prices for BTC Health have risen by 25% to A$0.045, marking the highest level since November 2022.

This rise came following the announcement by the biotechnology company that its unit signed an exclusive distribution agreement with Micrel Medical Devices S.A.

According to this agreement, BTC Health is granted exclusive sales and distribution rights for Rhythm Evolution infusion pumps in Australia and New Zealand.

Despite this recent surge, the company’s stock price is down 2.7% year-to-date.

BTC Health is a biotechnology company engaged in providing health solutions.